Article Information
History
- December 11, 2021.
Article Versions
- Version 1 (August 21, 2021 - 23:13).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Elisabetta Colosi1,
- Giulia Bassignana1,
- Diego Andrés Contreras2,
- Canelle Poirier1,
- Pierre-Yves Boëlle1,
- Simon Cauchemez3,
- Yazdan Yazdanpanah4,5,
- Bruno Lina6,7,
- Arnaud Fontanet8,9,
- Alain Barrat2,10 and
- Vittoria Colizza1,10,*
- 1INSERM, Sorbonne Université, Pierre Louis Institute of Epidemiology and Public Health, Paris, France
- 2Aix Marseille Univ, Université de Toulon, CNRS, CPT, Turing Center for Living Systems, Marseille, France
- 3Mathematical Modelling of Infectious Diseases Unit, Institut Pasteur, UMR2000, CNRS, Paris, France
- 4Infection, Antimicrobials, Modelling, Evolution, INSERM, Université de Paris, Paris, France
- 5Bichat Claude Bernard Hospital, Assistance publique–Hôpitaux de Paris, Paris, France
- 6National Reference Center for Respiratory Viruses, Department of Virology, Infective Agents Institute, Croix-Rousse Hospital, Hospices Civils de Lyon, Lyon, France
- 7Virpath Laboratory, International Center of Research in Infectiology, INSERM U1111, CNRS—UMR 5308, École Normale Supérieure de Lyon, Université Claude Bernard Lyon, Lyon University, Lyon, France
- 8Emerging Diseases Epidemiology Unit, Institut Pasteur, Paris, France
- 9PACRI Unit, Conservatoire National des Arts et Metiers, Paris, France
- 10Tokyo Tech World Research Hub Initiative (WRHI), Tokyo Institute of Technology, Tokyo, Japan
- ↵* Corresponding author; email: vittoria.colizza{at}inserm.fr